Cancer Care Ontario | Cancer Care Ontario

7 Results

Guidelines and Advice

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

Status: Education and Information
ID: 1-24 Version 2
Version: 2

May 2006

Guidelines and Advice

Status: Archived
ID: CED 3

Jan 2006

Guidelines and Advice

Status: Archived
ID: CED 2
Version: 2

Jan 2006

Guidelines and Advice

Status: Archived
ID: 13-8

Oct 2006

Guidelines and Advice

Status: Current
ID: GL-C50-03

Apr 2006

Drug

Other Name(s): Mekinist®

Quick Link(s):

Jun 2025

Regimen

Cancer Type:

Skin,

Melanoma

Show More Show more tags

Intent: Palliative

Funding:

Exceptional Access Program

trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria

Drugs Used:

Quick Link(s):

Jun 2025